deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT01959295

Phase III Study of ASP2151 in Herpes Simplex Patients

Phase III Study of ASP2151 in Herpes Simplex Patients - A Double-blind, Placebo-controlled Study -

Sponsor: Maruho Co., Ltd.

Conditions Herpes Simplex
Updated 7 times since 2017 Last updated: Oct 2, 2024 Started: Aug 31, 2013 Primary completion: Apr 30, 2015 Completion: Apr 27, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Herpes Simplex, this trial is completed. The trial is conducted by Maruho Co., Ltd. and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshotCompleted~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshotCompleted~Nov 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Nov 2024 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Nov 2024 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE3

Show 2 earlier versions
  1. Jun 2018 — Sep 2020 [monthly]

    Completed PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Maruho Co., Ltd.
Data source: Maruho Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .